Trial intelligence / Profile preview

Acute Effects of Combusted and Vaporized Cannabis Inhalation Compared to Tobacco Cigarette Combustion

NCT07694466Phase 1Not yet recruiting

Start
Dec 2026
Primary completion
Feb 2027
Countries
1
01

Overview

Phase 1 trial of dronabinol (3 arms). Primary endpoints: Exhaled Breath Condensate at 180 minutes, Breath Volatile Organic Compound at 180 minutes and 1 more. Planned start Dec 2026; status: not yet recruiting.

02

Drugs

dronabinol

Beyond the preview

Go deeper on NCT07694466.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07694466.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call